VB
Vincent Bucci
Director

Vincent Bucci insider trades: Angiodynamics (ANGO) stock purchases

Director, Angiodynamics Last trade Oct 18, 2013 30 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
17
Open-market trades
since 2005
2
Companies
last trade 2013

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Vincent reports to the SEC

Open-market buys and sales

17 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 18, 2013ANGO↑ Buy$76K
Mar 12, 2013ANGO↑ Buy$431K
Mar 12, 2013ANGO↑ Buy$377K
Mar 12, 2013ANGO↑ Buy$108K
Feb 14, 2013ANGO↑ Buy$24K
Apr 12, 2012ANGO↑ Buy$47K
Apr 9, 2012ANGO↑ Buy$24K
Feb 21, 2012ANGO↑ Buy$27K
Feb 15, 2012ANGO↑ Buy$39K
Aug 16, 2011ANGO↑ Buy$42K
Aug 16, 2011ANGO↑ Buy$42K
Jun 8, 2005RITA↑ Buy$29K
Jun 7, 2005RITA↑ Buy$46K
Jun 6, 2005RITA↑ Buy$30K
Jun 3, 2005RITA↑ Buy$28K
Jun 2, 2005RITA↑ Buy$32K
Jun 1, 2005RITA↑ Buy$54K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANGO insiders

Open-market trades in the last 12 months

About Vincent Bucci's insider trades

Vincent Bucci is a director at Angiodynamics (ANGO). Since Jun 1, 2005, Vincent has reported 17 open-market purchases worth $1.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (15 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANGO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.